An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for prohibited acts and penalties.

HB 377 adds tianeptine - a medication sometimes misused as an opioid substitute - to Pennsylvania's list of prohibited substances under the Controlled Substance Act. It makes it illegal for unregistered individuals or unlicensed practitioners to manufacture, deliver, or possess tianeptine with intent to distribute. Violators face felony charges punishable by up to five years in prison, a $15,000 fine, or both. The bill directly affects healthcare providers, pharmacies, and anyone handling tianeptine without proper authorization under state drug laws. This amendment updates existing penalties to address emerging misuse of tianeptine.